The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenedrive Share News (GDR)

Share Price Information for Genedrive (GDR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.375
Bid: 4.25
Ask: 4.50
Change: 0.00 (0.00%)
Spread: 0.25 (5.882%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 4.375
GDR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK WINNERS & LOSERS SUMMARY: IPF Rises As June Collections Improve

Fri, 10th Jul 2020 10:43

(Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Friday.

----------

FTSE 100 - WINNERS

----------

Barclays, up 1.2%. Investec raised the lender to Buy from Hold.

----------

FTSE 250 - WINNERS

----------

Petropavlovsk, up 3.0%. The gold miner said Non-Executive Chair Peter Hambro, Chief Executive Alya Samokhvalova, Non-Executive Directors Johnny Smith, Martin Smith and Angelica Phillips will remain directors of the firm after the court requested a full hearing of Everest Alliance Ltd's application to remove them from their roles. Petropavlovsk said that while the judge found that Everest's complaints that the directors were not validly appointed were arguable, he declined to determine its application summarily and instead now requires a full hearing of Everest's application. Earlier on Friday, Everest - which has a 7.5% stake - requisitioned a general meeting to propose the hire of two new directors. The resolutions to be put forth at the meeting requested include the appointment of Paul Bushell and Ivan Kulakov as directors, the re-hire of James Cameron, Charlotte Phillipps, Katia Ray and Maxim Kharin in the event they have been removed as directors. Everest is looking to remove Hambro, Samokhvalova, Johnny Smith, Martin Smith and Phillips from the board. Everest also wants the removal of any other director that may have been appointed since Thursday until the end of the requisitioned meeting.

----------

FTSE 250 - LOSERS

----------

Senior, down 2.8%. The technology components manufacturer expressed a confident outlook going forward despite expecting to report a revenue fall in the first half of 2020. Senior reported a "robust" cash performance in the six months to the end of June, with GBP3 million net cash inflow generated during the period, in the face of "significant disruption" to its end markets. The company said it now expects revenue in the first half of 2020 to be around 30% lower than GBP580.4 million generated in the first half of 2019. Senior said net debt is expected to be GBP239 million at June 30, an improvement of GBP3 million from the end of December 2019. In 2019, in order to counter the anticipated decline in sales, Senior initiated a restructuring plan. Reflecting the additional actions which the company is taking, it now expects the total restructuring charge to be up to GBP35 million, an increase from the GBP23 million originally anticipated. Going forward, Senior said trading for the rest of 2020 continues to be hurt by Covid-19. As a result, guidance for 2020 remains suspended.

----------

OTHER MAIN MARKET AND AIM - WINNERS

----------

Marston's, up 2.5%. JPMorgan resumed the brewer with Neutral.

----------

International Personal Finance, up 15%. The home credit business said it is "well-placed" going forward as its collections effectiveness continued to improve in June. The company said it is encouraged by the extent to which the company is now stabilising into a "new normal" operational environment. International Personal Finance said collections effectiveness continued to improve in June, reaching 88% of pre-Covid expectations. It was at 76% in April and 80% in May. Going forward, the company said it expects collections effectiveness to progressively improve in the coming months. International Personal Finance said there is a continuing strong demand for its products. As lockdown restrictions are progressively relaxed and the company's collections effectiveness is improved, it said it has increased credit issued. In June, the company lent 37% of pre-Covid expectations, up from 30% during both of April and May.

----------

SRT Marine Systems, up 19%. The maritime surveillance provider announced the resumption of its Philippines fisheries management system project, with a significant cash payment being received in the week. The revised Philippines project plan agreed with SRT's customer is looking to accelerate implementation to make up for as much time lost as possible due to the five month pause. Meanwhile, in the Middle East final contract negotiations have recommenced and subject to completion of internal processes, these are expected to conclude soon with the projects starting in the coming months. Finally, SRT's Transcievers business has performed better than expected despite the current circumstances, achieving gross sales in the first quarter ended June 30 up 2% from the same period the year before.

----------

Focusrite, up 6.1%. The AIM-listed music & audio products company said revenue and profit are currently ahead of the company's expectations for the year to the end of August. Focusrite noted that the demand for its Audio Engineering and ADAM Audio products has been strong during the widespread lockdowns that have occurred as a result of Covid-19, thanks to widespread availability globally through e-commerce platforms. In addition, consumer registrations of products primarily focused on home recording equipment have risen. Conversely, demand for Martin Audio products has been significantly lower than pre-Covid levels of expectation due to the suspension of live music tours and festivals, although demand is now starting to show modest signs of recovery driven by the installed sound segment. Similarly, Focusrite Pro has seen muted performance as well, although the pipeline across education, post-production and installed sound is now showing signs of recovery.

----------

OTHER MAIN MARKET AND AIM - LOSERS

----------

Genedrive, down 13%. The molecular diagnostics firm expects its full year revenue to be sharply lower but in line with internal guidance. For the year to June 30, Genedrive expects its revenue to come in at GBP1.0 million from GBP2.4 million the year before. Looking ahead, Genedrive said it has received "significant" interest in its 96 SARS-CoV-2 kit, but obtaining regulatory approval is "taking longer than anticipated" and the regulatory agencies the firm is dealing with is "unable to provide definitive timelines for approvals".

----------

By Paul McGowan; paulmcgowan@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
29 Mar 2022 13:04

Genedrive rallies on positive news about hearing loss test

(Sharecast News) - Molecular diagnostics company Genedrive rallied on Tuesday after the UK's National Institute of Clinical Excellence (NICE) issued a new Medtech Innovation Briefing on its MT-RNR1 hearing loss test.

Read more
29 Mar 2022 10:32

Genedrive soars as UK public health body reviews hearing loss test

(Alliance News) - Genedrive PLC said on Tuesday that the UK National Institute of Clinical Excellence gave the company's MT-RNR1 hearing loss test a new Medtech Innovation Briefing.

Read more
22 Mar 2022 16:09

UK earnings, trading statements calendar - next 7 days

Wednesday 23 March 
Dignity PLCFull Year Results
ECSC Group PLCFull Year Results
Halma PLCTrading Statement
Surgical Innovations Group PLCFull Year Results
Henry Boot PLCFull Year Results
Judges Scientific PLCFull Year Results
Pendragon PLCFull Year Results
Saga PLCFull Year Results
SigmaRoc PLCFull Year Results
Ultra Electronics Holdings PLCFull Year Results
Petrofac LtdFull Year Results
Thursday 24 March 
Arbuthnot Banking Group PLCFull Year Results
Atalaya Mining PLCFull Year Results
Big Technologies PLCFull Year Results
Biome Technologies PLCFull Year Results
Bridepoint Group PLCFull Year Results
CVS Group PLCHalf Year Results
Energean PLCFull Year Results
EnQuest PLCFull Year Results
Eve Sleep PLCFull Year Results
International Public Partnerships LtdFull Year Results
Kin & Carta PLCFull Year Results
Next PLCFull Year Results
Robinson PLCFull Year Results
Safestyle UK PLCFull Year Results
Secure Trust Bank PLCFull Year Results
Sopheon PLCFull Year Results
Starwood European Real Estate LtdFull Year Results
WAG Payment Solutions PLCFull Year Results
Friday 25 March 
Electrocomponents PLCTrading Statement
Faron Pharmaceuticals LtdFull Year Results
Smiths Group Half Year Results
United Utilities Group PLCTrading Statement
Wickes Group PLCFull Year Results
Monday 28 March 
Dialight PLCFull Year Results
Hercules Site Services PLCFull Year Results
RTC Group PLCFull Year Results
LungLife AI IncFull Year Results
Octopus Renewables Infrastructure Trust PLCFull Year Results
Tuesday 29 March 
AG Barr PLCFull Year Results
Animalcare Group PLCFull Year Results
Aquis Exchange PLCFull Year Results
Artisanal Spirits Co PLCFull Year Results
Bellway PLCHalf Year Results
Burford Capital LtdFull Year Results
Central Asia Metals PLCFull Year Results
Ergomed PLCFull Year Results
FireAngel Safety Technology Group PLCFull Year Results
Genedrive PLCHalf Year Results
Good Energy Group PLCFull Year Results
IQE PLCFull Year Results
Mortgage Advice Bureau Holdings PLCFull Year Results
NAHL Group PLCFull Year Results
Personal Group Holdings PLCFull Year Results
RBG Holdings PLCFull Year Results
Regional REIT LtdFull Year Results
S&U PLCFull Year Results
SkinBioTherapeutics PLCHalf Year Results
SSE PLCTrading Statement
Ten Entertainment Group PLCFull Year Results
Xaar PLCFull Year Results
XLMedia PLCFull Year Results
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
21 Mar 2022 19:11

TRADING UPDATES: Kavango eyes acquisition; PYX ups zicron price

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
18 Mar 2022 20:28

TRADING UPDATES: Elixirr buys in US; JPMorgan Russian wary of values

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

Read more
18 Mar 2022 16:53

LONDON MARKET CLOSE: Stocks edge higher in cautious end to busy week

(Alliance News) - European equities closed slightly higher on Friday, ending a stacked week in slightly muted fashion, though stocks grew in confidence over the course of the afternoon after Chinese leader Xi Jinping condemned Russia's invasion of Ukraine.

Read more
17 Mar 2022 14:16

EXECUTIVE CHANGES: Young's promotes new CEO; Centrica replaces Hester

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Wednesday and Thursday and not separately reported by Alliance News:

Read more
2 Mar 2022 14:57

Genedrive finance chief announces April departure

(Sharecast News) - Molecular diagnostics company Genedrive said on Wednesday that its chief financial officer Matthew Fowler would be leaving it and stepping down from the board on 19 April.

Read more
23 Feb 2022 15:34

Genedrive makes progress with rapid Covid-19 test kit

(Sharecast News) - Molecular diagnostics company Genedrive updated the market on progress on the 'Genedrive COV19-ID' kit - its rapid point of care molecular test for Covid-19 - on Wednesday.

Read more
23 Feb 2022 14:22

IN BRIEF: Genedrive wins distribution agreements for Covid-19 test

Genedrive PLC - Manchester-based molecular diagnostics company - Enters into distribution agreements covering Spain, Portugal, Oman and the United Arab Emirates for its Covid-19 test kit. The company says these initial distributor arrangements are designed to access and assess the longer-term market potential in each country. Genedrive says end-user product evaluation in the UK is currently ongoing and Covid-19 test device approval is pending.

Read more
23 Feb 2022 11:41

AIM WINNERS & LOSERS: eve Sleep shares awakened by DFS Furniture deal

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
23 Dec 2021 15:54

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
22 Dec 2021 11:34

Genedrive shares soar as files for UK approval of Covid testing kit

Genedrive shares soar as files for UK approval of Covid testing kit

Read more
22 Dec 2021 11:28

AIM WINNERS & LOSERS: BlueRock hit by Covid; D4T4 up on contract wins

AIM WINNERS & LOSERS: BlueRock hit by Covid; D4T4 up on contract wins

Read more
9 Dec 2021 12:26

TRADING UPDATES: Genedrive's Covid test kit gets EU approval

TRADING UPDATES: Genedrive's Covid test kit gets EU approval

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.